Drug intelligence / Profile preview

azithromycin + fluconazole + ornidazole

Development stage
Unknown
Lead developer
Systopic Laboratories
Modality
Small Molecules
Administration
Oral
01

Overview

AF-Kit is a combination anti-infective product marketed by Systopic Laboratories. It is formulated as a combipack containing three active ingredients: azithromycin (a macrolide antibiotic), fluconazole (an azole antifungal), and ornidazole (a nitroimidazole antiprotozoal/antibacterial). AF-Kit is primarily indicated for the syndromic treatment of mixed vaginal infections and abnormal vaginal discharge, including bacterial vaginosis, vaginal candidiasis (yeast infections), and trichomoniasis. Azithromycin works by inhibiting bacterial protein synthesis via binding to the 50S ribosomal subunit. Fluconazole inhibits fungal ergosterol synthesis by targeting lanosterol 14-alpha-demethylase, thereby disrupting fungal cell membrane integrity. Ornidazole is reduced to reactive intermediates that damage microbial DNA, leading to cell death in anaerobic bacteria and protozoa.

Brand names
AF KitAF-Kit
Other names
azithromycin + ornidazole + fluconazoleazithromycin, fluconazole, and ornidazolefluconazole + azithromycin + ornidazole
02

Targets

Bacterial 50S ribosomal subunitNeuraminidaseDNACYP51A1 (Sterol 14α-demethylase)

Beyond the preview

Go deeper on azithromycin + fluconazole + ornidazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on azithromycin + fluconazole + ornidazole.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call